Stay updated on Long-term Safety of UCART19 in Lymphoid Leukemia Clinical Trial
Sign up to get notified when there's something new on the Long-term Safety of UCART19 in Lymphoid Leukemia Clinical Trial page.

Latest updates to the Long-term Safety of UCART19 in Lymphoid Leukemia Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedThe page adds a dedicated Locations section listing California, Colorado, Florida, Massachusetts, Pennsylvania, and Texas, and removes the HHS Vulnerability Disclosure item from the footer.SummaryDifference0.7%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page now lists Revision: v3.3.2, replacing Revision: v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedA platform version update is shown, with Revision: v3.3.1 added and Revision: v3.2.0 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedThe government funding/operating status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check69 days agoChange DetectedNo meaningful additions or deletions were detected on the Study Details page; core information such as study title, objectives, eligibility criteria, and participating sites appears unchanged.SummaryDifference0.4%

- Check98 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment with potential service impact; previous version reference (v3.1.0) was removed.SummaryDifference4%

Stay in the know with updates to Long-term Safety of UCART19 in Lymphoid Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Safety of UCART19 in Lymphoid Leukemia Clinical Trial page.